鼻内镜评分阈值触发慢性鼻窦炎治疗升级的考量及其对疾病控制的启示
研究纳入29名鼻科医生,基于改良Lund-Kennedy(MLK)评分与鼻息肉评分(NPS)的所有可能组合,询问在无症状及有1项困扰性症状时是否考虑升级慢性鼻窦炎(CRS)治疗。结果显示MLK评分≥4或NPS≥3的中位阈值可触发治疗升级考量。
要点
- MLK评分中位阈值≥4,75.9%参与者的阈值在4分附近1分内。
- NPS中位阈值≥3,62.5%参与者的阈值在3分附近1分内。
- 存在1项困扰性症状时内镜评分阈值降低。
核心结论
- 反映多样鼻科医生实践模式,MLK评分≥4或NPS≥3可作为考虑CRS治疗升级的阈值。
- MLK评分低于4或NPS低于3可作为CRS治疗的内镜目标。
- 结果为使用鼻内镜发现作为CRS疾病控制标准提供指导。
研究设计与样本
- 参与者为29名多样化的鼻科医生。
- 向参与者呈现由MLK评分(范围0-12)和NPS(范围0-8)代表的所有双边鼻内镜发现组合。
- 询问在无CRS症状及有1项困扰性CRS症状时是否考虑治疗升级及升级强度。
主要发现
- 考虑治疗升级的MLK总评分中位阈值≥4,75.9%参与者的MLK阈值在4分附近1分内。
- 考虑治疗升级的NPS总评分中位阈值≥3,62.5%参与者的NPS阈值在3分附近1分内。
- 存在1项困扰性症状时内镜评分阈值降低,需要更强确认时阈值通常增加。
临床怎么用
- MLK评分≥4或NPS≥3可作为考虑CRS治疗升级的阈值。
- MLK评分低于4或NPS低于3可作为CRS治疗的内镜目标。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the absence of direct evidence supporting how to use nasal endoscopy findings to judge chronic rhinosinusitis (CRS) disease control, experts' practice patterns could provide guidance. METHODOLOGY: Participants consisted of a diverse group of twenty-nine rhinologists. Participants were presented with every possible combination of bilateral nasal endoscopy findings represented by the modified Lund-Kennedy (MLK; range: 0-12) endoscopic scoring system and Nasal Polyp Score (NPS; range: 0-8). Reflecting the practical consequence of CRS disease control assessment, participants were asked whether they would consider CRS treatment escalation based on each scenario in the absence of any CRS symptoms, and how strongly they considered escalating therapy. The same scenarios were then presented in the context of 1 burdensome CRS symptom and participants again were asked whether they would consider treatment escalation. RESULTS: The median threshold total MLK score for considering treatment escalation was ≥ 4 and 75.9% of participants' MLK thresholds were within 1 point of 4. The median threshold total NPS for considering treatment escalation was ≥ 3 and 62.5% of participants' NPS thresholds were within 1 point of 3. Endoscopy score thresholds decreased in the presence of 1 burdensome symptom and generally increased when requiring stronger affirmation for considering CRS treatment escalation. CONCLUSION: Reflecting the practice patterns of a diverse group of rhinologists, MLK score ≥ 4 or NPS ≥ 3 may serve as thresholds for considering CRS treatment escalation. Alternatively, MLK score under 4 or NPS under 3 may serve as endoscopic goals of CRS treatment. These results provide guidance for using nasal endoscopy findings as a criterion of CRS disease control.
引用
- Sedaghat AR, Cotter RA, Alobid I, et al. Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease control. Rhinology. 2025. PMID: 39385734. doi:10.4193/Rhin24.291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。